AU1993599A - Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant - Google Patents

Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant Download PDF

Info

Publication number
AU1993599A
AU1993599A AU19935/99A AU1993599A AU1993599A AU 1993599 A AU1993599 A AU 1993599A AU 19935/99 A AU19935/99 A AU 19935/99A AU 1993599 A AU1993599 A AU 1993599A AU 1993599 A AU1993599 A AU 1993599A
Authority
AU
Australia
Prior art keywords
surfactant
glucocorticosteroid
micelles
composition
aqueous medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19935/99A
Other languages
English (en)
Inventor
Gabrielle Sjoquist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU1993599A publication Critical patent/AU1993599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU19935/99A 1997-12-22 1998-12-22 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant Abandoned AU1993599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (sv) 1997-12-22 1997-12-22 New formulation
SE9704833 1997-12-22
PCT/SE1998/002426 WO1999032089A1 (en) 1997-12-22 1998-12-22 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant

Publications (1)

Publication Number Publication Date
AU1993599A true AU1993599A (en) 1999-07-12

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19935/99A Abandoned AU1993599A (en) 1997-12-22 1998-12-22 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant

Country Status (20)

Country Link
EP (1) EP1043973A1 (no)
JP (1) JP2001526210A (no)
KR (1) KR20010024789A (no)
CN (1) CN1283106A (no)
AR (1) AR017220A1 (no)
AU (1) AU1993599A (no)
BR (1) BR9813811A (no)
CA (1) CA2315782A1 (no)
EE (1) EE200000388A (no)
HU (1) HUP0102365A3 (no)
ID (1) ID26945A (no)
IL (1) IL136880A0 (no)
NO (1) NO20003220L (no)
NZ (1) NZ505073A (no)
PL (1) PL341361A1 (no)
SE (1) SE9704833D0 (no)
SK (1) SK9532000A3 (no)
TR (1) TR200001977T2 (no)
WO (1) WO1999032089A1 (no)
ZA (1) ZA9811461B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (sv) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
SE0100901D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2005018607A1 (ja) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. 溶解性を改善した医薬品製剤
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
US20090143343A1 (en) 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
CA2704946C (en) * 2007-11-13 2013-09-24 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
MX2011002688A (es) * 2008-09-12 2011-04-12 Critical Pharmaceuticals Ltd Mejoramientos en la absorcion de agentes terapeuticos a traves de las membranas mucosas o la piel.
CN101982168B (zh) * 2010-11-02 2012-05-23 山东大学 一种槲皮素纳米胶束制剂及其制备方法
CN102793678B (zh) * 2011-05-26 2017-06-30 邓世明 一种不含吐温的多烯紫杉醇注射剂的制备方法
DE102011108948A1 (de) * 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
JP5456802B2 (ja) * 2012-01-23 2014-04-02 株式会社Ｃａｃ 細胞遊走促進剤及び創傷治療用の経皮吸収剤
US10596115B2 (en) * 2013-07-17 2020-03-24 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
KR102086316B1 (ko) * 2019-09-09 2020-03-09 한국콜마주식회사 경피흡수성이 우수한 화장료 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Also Published As

Publication number Publication date
HUP0102365A3 (en) 2002-01-28
SK9532000A3 (en) 2000-11-07
ZA9811461B (en) 1999-06-22
NO20003220L (no) 2000-08-22
SE9704833D0 (sv) 1997-12-22
WO1999032089A1 (en) 1999-07-01
CN1283106A (zh) 2001-02-07
EE200000388A (et) 2002-02-15
IL136880A0 (en) 2001-06-14
HUP0102365A2 (hu) 2001-11-28
JP2001526210A (ja) 2001-12-18
NZ505073A (en) 2002-09-27
BR9813811A (pt) 2000-10-03
AR017220A1 (es) 2001-08-22
CA2315782A1 (en) 1999-07-01
TR200001977T2 (tr) 2000-12-21
PL341361A1 (en) 2001-04-09
ID26945A (id) 2001-02-22
EP1043973A1 (en) 2000-10-18
KR20010024789A (ko) 2001-03-26
NO20003220D0 (no) 2000-06-21

Similar Documents

Publication Publication Date Title
AU1993599A (en) Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant
DE69928665T2 (de) Kortikosteroide enthaltende wässrige Zusammensetzungen zum nasalen oder pulmonalen Zuführen
US9017728B2 (en) Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
US6258374B1 (en) Foam-forming pharmaceutical composition
JP5001657B2 (ja) 噴霧化用のシクレソニドの水性懸濁液
US20120022032A1 (en) Corticosteroid compositions and methods of treatments thereof
WO2019214715A1 (zh) 一种美洛昔康组合物、制剂及其制备方法与应用
US20210251903A1 (en) Preparation of Microparticulate Triamcinolone Acetonide Injectable Suspension
US20220370359A1 (en) Fulvestrant pharmaceutical composition, preparation method therefor, and application thereof
US20210379080A1 (en) Intranasal Formulation
US8466134B1 (en) Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
CZ20002298A3 (cs) Farmaceutický prostředek, obsahující micely ve vodném prostředí, a způsob jeho přípravy
MXPA00006161A (en) Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant
KR20060012030A (ko) 디아제팜을 함유하는 경비 마이크로에멀젼
JPH08151332A (ja) 点鼻用水性懸濁液
KR20200125923A (ko) 빌라스틴 및 모메타손을 포함하는 수성 조성물
JP3470131B2 (ja) 持効性点鼻剤
US11433084B2 (en) Preparation of microparticulate methylprednisolone acetate suspension
CN118317771A (zh) 用于局部治疗布鲁里溃疡中的溃疡分枝杆菌的制剂和方法
CN1750810A (zh) 低剂量皮质类固醇组合物

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted